CONFIDENTIALITY DEAL
October 1st, 2004
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMEA) and the USA's Food and Drug Administration will stage a pilot of their new confidentiality agreement aimed at enabling pharmaceutical companies to obtain parallel advice from the two bodies. The deal involves exchanging information, including on pre-authorisation and post-authorisation applications, inspections and guidance documents. *Details
*http://www.emea.eu.int/pdfs/general/direct/pr/93356en04.pdf
THE EUROPEAN Medicines Agency (EMEA) and the USA's Food and Drug Administration will stage a pilot of their new confidentiality agreement aimed at enabling pharmaceutical companies to obtain parallel advice from the two bodies. The deal involves exchanging information, including on pre-authorisation and post-authorisation applications, inspections and guidance documents. *Details
*http://www.emea.eu.int/pdfs/general/direct/pr/93356en04.pdf
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.